1.Hay SI, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abebo TA, Abera SF: Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390(10100):1260–1344.
2.Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, Aboyans V, Adetokunboh O, Afshin A, Agrawal A: Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390(10100):1151–1210.
3.Australian Institute of Health and Welfare: Australia’s health 2018. In. Edited by AIHW. Canberra; 2018. https://www.aihw.gov.au/getmedia/fe037cf1–0cd0–4663-a8c0–67cd09b1f30c/aihw-aus–222.pdf.aspx?inline = true
4.Australian Bureau of Statistics: Causes of Death, Australia, 2017. https://www.abs.gov.au/ausstats/[email protected]/mf/3303.0
5.Australian Bureau of Statistics: National Health Survey: first results 2014–15. Canberra: ABS. 2015. https://www.ausstats.abs.gov.au/ausstats/subscriber.nsf/0/CDA852A349B4CEE6CA257F150009FC53/$File/national%20health%20survey%20first%20results,%202014–15.pdf
6.Wang L, Palmer AJ, Cocker F, Sanderson K: Multimorbidity and health-related quality of life (HRQoL) in a nationally representative population sample: implications of count versus cluster method for defining multimorbidity on HRQoL. Health Qual Life Outcomes. 2017;15(1):7.
7.Atlantis E, Sullivan T, Sartorius N, Almeida OP: Changes in the prevalence of psychological distress and use of antidepressants or anti-anxiety medications associated with comorbid chronic diseases in the adult Australian population, 2001–2008. Aust N Z J Psychiatry. 2012;46(5):445–456.
8.Gallacher KI, McQueenie R, Nicholl B, Jani BD, Lee D, Mair FS: Risk factors and mortality associated with multimorbidity in people with stroke or transient ischaemic attack: a study of 8,751 UK Biobank participants. JOC. 2018;8(1):1–8.
9.Condelius A, Edberg A-K, Jakobsson U, Hallberg IR: Hospital admissions among people 65+ related to multimorbidity, municipal and outpatient care. Arch Gerontol Geriat. 2008;46(1):41–55.
10.Wolff JL, Starfield B, Anderson G: Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Int Med. 2002;162(20):2269–2276.
11.Vyas A, Pan X, Sambamoorthi U: Chronic condition clusters and polypharmacy among adults. Int J Famiy Med. 2012; 193168.
12.Atlantis E, Lange K, Wittert GA: Chronic disease trends due to excess body weight in Australia. Obes Rev. 2009;10(5):543–553.
13.Foreman KJ MN, Dolgert A, Fukutaki K, McGaughey M, Pletcher MA, et al.: Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories using data from the Global Burden of Disease Study 2016. The Lancet. 2018;392(10159):2052–2090.
14.Ford ES, Capewell S: Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. Annu Rev Public Health. 2011;32:5–22.
15.Divo MJ, Martinez CH, Mannino DM: Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44(4):1055–68.
16.Lunenfeld B, Stratton P: The clinical consequences of an ageing world and preventive strategies. Best Pract Res Clin Obstet Gynaecol. 2013;27(5):643–659.
17.Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B: Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet. 2012;380(9836):37–43.
18.Camacho EM, Davies LM, Hann M, Small N, Bower P, Chew-Graham C, Baguely C, Gask L, Dickens CM, Lovell K: Long-term clinical and cost-effectiveness of collaborative care (versus usual care) for people with mental–physical multimorbidity: cluster-randomised trial. Br J Psychiatry. 2018: 213(2):456–463.
19.Coventry P, Lovell K, Dickens C, Bower P, Chew-Graham C, McElvenny D, Hann M, Cherrington A, Garrett C, Gibbons CJ: Integrated primary care for patients with mental and physical multimorbidity: cluster randomised controlled trial of collaborative care for patients with depression comorbid with diabetes or cardiovascular disease. BMJ. 2015;350:h638.
20.O’Loughlin M, Mills J, McDermott R, Harriss L: Review of patient-reported experience within Patient-Centered Medical Homes: insights for Australian Health Care Homes. Aust J Prim Health. 2017;23(5):429–439.
21.Australian Nursing Federation. Primary health care in Australia: A nursing and midwifery consensus view. 2009. https://anmf.org.au/documents/reports/PHC_Australia.pdf
22.Department of Health. National Primary Health Care Strategic Framework. 2013. https://www.health.gov.au/internet/main/publishing.nsf/Content/6084A04118674329CA257BF0001A349E/$File/NPHCframe.pdf
23.Commonwealth of Australia: National primary health care strategic framework. 2016.
24.Department of Health: Australian Primary Care Collaboratives Programme. 2014. https://www.health.gov.au/internet/main/publishing.nsf/Content/health-pcd-programs-apccp-index.htm
25.Canaway R, Boyle DI, Manski‐Nankervis JAE, Bell J, Hocking JS, Clarke K, Clark M, Gunn JM, Emery JD: Gathering data for decisions: best practice use of primary care electronic records for research. Med J Aust. 2019;210:S12-S16.
26.Winzenberg TM, Gill GF: Prioritising general practice research. Med J Aust. 2016; 205(2):55–57.
27.Jackson GL, Powers BJ, Chatterjee R, Bettger JP, Kemper AR, Hasselblad V, Dolor RJ, Irvine RJ, Heidenfelder BL, Kendrick AS: The patient-centered medical Home: A Systematic review. Ann Intern Med. 2013;158(3):169–178.
28.Australian Medical Association. AMA Position Statement on the Medical Home - 2015. https://ama.com.au/position-statement/ama-position-statement-medical-home
29.Bodenheimer T, Ghorob A, Willard-Grace R, Grumbach K: The 10 building blocks of high-performing primary care. Ann Fam Med. 2014;12(2):166–171.
30.Berk‐Clark C, Doucette E, Rottnek F, Manard W, Prada MA, Hughes R, Lawrence T, Schneider FD: Do Patient‐Centered Medical Homes Improve Health Behaviors, Outcomes, and Experiences of Low‐Income Patients? A Systematic Review and Meta‐Analysis. Health Serv Res. 2018; 53(3): 1777–1798.
31.Maeng DD, Graf TR, Davis DE, Tomcavage J, Bloom Jr FJ: Can a patient-centered medical home lead to better patient outcomes? The quality implications of Geisinger’s ProvenHealth Navigator. Am J Med Qual. 2012;27(3):210–216.
32.Bitton A, Martin C, Landon BE: A Nationwide Survey of Patient Centered Medical Home Demonstration Projects. J Gen Intern Med. 2010;25(6):584–592.
33.DeVries A, Li C-HW, Sridhar G, Hummel JR, Breidbart S, Barron JJ: Impact of medical homes on quality, healthcare utilization, and costs. Am J Manag Care. 2012; 18(9):534–544.
34.Peikes D, Chen A, Schore J, Brown R: Effects of care coordination on hospitalization, quality of care, and health care expenditures among medicare beneficiaries: 15 randomized trials. JAMA. 2009;301(6):603–618.
35.Reid RJ, Fishman PA, Yu O, Ross TR, Tufano JT, Soman MP, Larson EB: Patient-centered medical home demonstration: a prospective, quasi-experimental, before and after evaluation. Am J Manag Care. 2009;15(9):e71–87.
36.Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for Diagnosis, Management, and Prevention of COPD—2016. https://goldcopd.org/global-strategy-diagnosis-management-prevention-copd–2016/
37.Lampe L: Drug treatment for anxiety. Aust Prescr. 2013, 36(6):186–189.
38.National Heart Foundation of Australia: Guide to management of hypertension (2008 updated 2010). 2010. https://www.healthylivingnt.org.au/system/files/f/HypertensionGuidelines2008QRG2010Update.pdf
39.National Heart Foundation of Australia: Guideline for the diagnosis and management of hypertension in adults. Melbourne. 2016. https://www.heartfoundation.org.au/images/uploads/publications/PRO–167_Hypertension-guideline–2016_WEB.pdf
40.National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Guidelines for the prevention, detection and management of chronic heart failure in Australia. 2011. https://www.heartfoundation.org.au/images/uploads/publications/Chronic_Heart_Failure_Guidelines_2011.pdf
41.National Institute for Health and Care Excellence: Hypertension in adults: diagnosis and management. 2011. https://www.nice.org.uk/guidance/cg127
42.National Institute for Health and Care Excellence: Type 1 diabetes in adults: diagnosis and management. 2015. https://www.nice.org.uk/guidance/ng17
43.National Institute for Health and Care Excellence: Chronic heart failure in adults: diagnosis and management. 2018. https://www.nice.org.uk/guidance/ng106
44.National Institute for Health and Care Excellence: Recognition, assessment and initial management of depression in adults. 2018. http://pathways.nice.org.uk/pathways/depression
45.National Prescribing Service. Managing Blood Pressure based on Absolute Risk. 2016. https://www.nps.org.au/medical-info/clinical-topics/blood-pressure
46.National Prescribing Service. Blood pressure treatment targets. 2016. www.nps.org.au/conditions/heart-blood-and-blood-vessel-conditions/blood-pressure/for-health-professionals/managing-blood-pressure-based-on-absolute-risk/bp-treatment-targets
47.National Prescribing Service. Non-pharmacological management of depression. 2016. https://www.nps.org.au/news/medicinewise-news-exploring-non-drug-options-in-depression
48.National Prescribing Service. Understanding high blood pressure. 2017. www.nps.org.au/conditions/heart-blood-and-blood-vessel-conditions/blood-pressure/for-individuals/understanding-high-blood-pressure
49.National Vascular Disease Prevention Alliance: Guidelines for the management of absolute cardiovascular disease risk. 2012. https://www.heartfoundation.org.au/images/uploads/publications/Absolute-CVD-Risk-Full-Guidelines.pdf
50.The Royal Australian College of General Practitioners: General practice management of type 2 diabetes: 2016–18. East Melbourne. 2016. https://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/5d3298b2-abf3–487e–9d5e–0558566fc242.pdf
51.Yang I, Brown J, George J, Jenkins S, McDonald C, McDonald V, Smith B, Zwar N, Dabscheck E: The COPD-X Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2018.
52.Department of Health: Evaluation Report of the Diabetes Care Project. 2015. https://www.health.gov.au/internet/main/publishing.nsf/Content/302DF0372F537A43CA257E35000138E8/$File/DCP%20Evaluation%20Report.pdf
53.Primary Health Care Advisory Group: Better Outcomes for People with Chronic and Complex Health Conditions. 2016. https://www.health.gov.au/internet/main/publishing.nsf/Content/76B2BDC12AE54540CA257F72001102B9/$File/Primary-Health-Care-Advisory-Group_Final-Report.pdf
54.Leelani K: Impact on diabetes management of general practice management plans, team care arrangements and reviews. Med J Aust. 2013;199(4):261–265.
55.Andrews G, Slade T: Interpreting scores on the Kessler psychological distress scale (K10). Aust N Z J Public Health. 2001;25(6):494–497.
56.Chen L, Magliano DJ, Balkau B, Colagiuri S, Zimmet PZ, Tonkin AM, Mitchell P, Phillips PJ, Shaw JE. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust. 2010;192(4):197.
57.Henry JD, Crawford JR: The short‐form version of the Depression Anxiety Stress Scales (DASS‐21): Construct validity and normative data in a large non‐clinical sample. Br J Clin Psychol. 2005;44(2):227–239.
58.Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X: Development and preliminary testing of the new five-level version of EQ–5D (EQ–5D–5L). Qual Life Res. 2011;20(10):1727–1736.
59.Hibbard JH, Stockard J, Mahoney ER, Tusler M: Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4p1):1005–1026.
60.Jones P, Harding G, Berry P, Wiklund I, Chen W, Leidy NK: Development and first validation of the COPD Assessment Test. Eur Resp J. 2009;34(3):648–654.
61.Lyman S, Lee Y-Y, Franklin PD, Li W, Cross MB, Padgett DE: Validation of the KOOS, JR: a short-form knee arthroplasty outcomes survey. Clin Orthop Relat Res. 2016;474(6):1461–1471.
62.Lyman S, Lee Y-Y, Franklin PD, Li W, Mayman DJ, Padgett DE: Validation of the HOOS, JR: a short-form hip replacement survey. Clin Orthop Relat Res. 2016;474(6):1472–1482.
63.Sager MA, Rudberg MA, Jalaluddin M, Franke T, Inouye SK, Landefeld CS, Siebens H, Winograd CH: Hospital admission risk profile (HARP): identifying older patients at risk for functional decline following acute medical illness and hospitalization. J Am Geriatr Soc. 1996;44(3):251–257.
64.Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR: The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci. 2001;101(6):671–679.
65.Brett T, Arnold-Reed DE, Popescu A, Soliman B, Bulsara MK, Fine H, Bovell G, Moorhead RG: Multimorbidity in Patients Attending 2 Australian Primary Care Practices. Ann Fam Med. 2013;11(6):535–542.
66.Britt HC, Harrison CM, Miller GC, Knox SA: Prevalence and patterns of multimorbidity in Australia. Med J Aust. 2008;189(2):72–77.
67.Heyworth IT, Hazell ML, Linehan MF, Frank TL: How do common chronic conditions affect health-related quality of life? Br J Gen Pract. 2009;59(568):e353-e358.
68.Tan Z, Liang Y, Liu S, Cao W, Tu H, Guo L, Xu Y: Health-related quality of life as measured with EQ–5D among populations with and without specific chronic conditions: a population-based survey in Shaanxi Province, China. PLoS One. 2013;8(7):e65958.
69.Bravo P, Edwards A, Barr PJ, Scholl I, Elwyn G, McAllister M: Conceptualising patient empowerment: a mixed methods study. BMC Health Serv Res. 2015;15(1):252.
70.Reid RJ, Coleman K, Johnson EA, Fishman PA, Hsu C, Soman MP, Trescott CE, Erikson M, Larson EB: The group health medical home at year two: cost savings, higher patient satisfaction, and less burnout for providers. Health Aff. 2010;29(5):835–843.
71.Boult C, Reider L, Frey K, Leff B, Boyd CM, Wolff JL, Wegener S, Marsteller J, Karm L, Scharfstein D: Early effects of “Guided Care” on the quality of health care for multimorbid older persons: a cluster-randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2008;63(3):321–327.
72.Maeng DD, Graham J, Graf TR, Liberman JN, Dermes NB, Tomcavage J, Davis DE, Bloom FJ, Steele JG: Reducing long-term cost by transforming primary care: evidence from Geisinger’s medical home model. Am J Manag Care. 2012;18(3):149–155.
73.Sahlen K-G, Boman K, Brännström M: A cost-effectiveness study of person-centered integrated heart failure and palliative home care: based on a randomized controlled trial. Palliat Med. 2016;30(3):296–302.
74.Department of Health: Health Care Homes—Health professionals. 2016. https://www.health.gov.au/internet/main/publishing.nsf/Content/health-care-homes-professional
75.Western Australia Primary Health Alliance: Health Care Home - A model for primary health care. 2016. https://www.wapha.org.au/wp-content/uploads/2016/01/WAPHA-Health-Care-Home.pdf